Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Change in Accured Expenses (2020 - 2025)

Zai Lab's Change in Accured Expenses history spans 6 years, with the latest figure at $11.5 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 22.34% year-over-year to $11.5 million; the TTM value through Dec 2025 reached $4.8 million, up 121.57%, while the annual FY2025 figure was $4.8 million, 121.57% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $11.5 million at Zai Lab, up from $9.2 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $21.7 million in Q1 2021 and bottomed at -$34.2 million in Q1 2024.
  • The 5-year median for Change in Accured Expenses is $6.1 million (2021), against an average of $2.0 million.
  • The largest annual shift saw Change in Accured Expenses soared 1641.69% in 2021 before it tumbled 140.71% in 2022.
  • A 5-year view of Change in Accured Expenses shows it stood at $9.6 million in 2021, then tumbled by 39.65% to $5.8 million in 2022, then soared by 239.75% to $19.6 million in 2023, then dropped by 24.26% to $14.8 million in 2024, then fell by 22.34% to $11.5 million in 2025.
  • Per Business Quant, the three most recent readings for ZLAB's Change in Accured Expenses are $11.5 million (Q4 2025), $9.2 million (Q3 2025), and $7.3 million (Q2 2025).